Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Credit card cash back can be considered income under certain circumstances. Learn when this applies to ensure proper tax reporting.
23,406 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
When a well-known investment advisor unloads a large slice of a stock, it sparks questions. This guide breaks down wh...
SpaceX's post-IPO moves could ripple through the market. This guide explains what to watch, how to react, and smart s...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
A wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
Chip optimism propelled tech stocks higher as ceasefire reports sparked relief rallies. This guide breaks down what d...
Rigetti Computing stock rocketing headlines a broader burst of investor interest in quantum tech. Here’s what’s drivi...
The nuclear energy story 2026 is taking shape as decarbonization and power-hungry data demand push expansion. This gu...
Markets wobble as investors weigh ongoing AI-driven growth against macro and policy risks, highlighting wall street’s...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
When a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
Tesla stock can swing on headlines and catalysts. This guide shows you how to decide whether you should wait tesla st...